CClinicalTrials.gg
Active, not recruitingNCT07418476Updated Jul 14, 2026

Comparison of Standard ACL Reconstruction Versus TARS-Augmented Reconstruction

An interventional study of ACL Reconstruction and TARS-Augmented ACL Reconstruction in Anterior Cruciate Ligament (ACL), sponsored by Samsun University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-14.

Sponsored by Samsun University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study is designed to compare standard anterior cruciate ligament (ACL) reconstruction using hamstring autograft with ACL reconstruction augmented using the Tape Active Reconstruction System (TARS). Eligible patients aged 18 to 44 years with a complete ACL rupture will be prospectively enrolled and randomized in a 1:1 ratio into two study groups. Participants will be evaluated preoperatively and postoperatively at regular follow-up visits, with the final assessment performed at 12 months after surgery. Outcome assessments will include patient-reported outcome measures, objective clinical examination of knee stability, instrumented laxity measurements, and radiological evaluation.

Read the detailed description

Anterior cruciate ligament reconstruction is one of the most commonly performed procedures in sports orthopaedic surgery. Although standard hamstring autograft reconstruction provides good clinical outcomes, residual anterior knee laxity and graft failure remain concerns, particularly in young and active patients. Augmentation using the Tape Active Reconstruction System (TARS) has been introduced as an adjunct technique intended to share load with the graft during the early healing phase and potentially improve postoperative stability.

The aim of this study is to evaluate whether ACL reconstruction augmented using TARS results in superior clinical, functional, and radiological outcomes compared with standard ACL reconstruction alone. The study will prospectively collect demographic, clinical, functional, and imaging data and analyze the relationship between surgical technique and postoperative outcomes. Patients will be evaluated preoperatively and at 12 months postoperatively. Assessments will include objective knee stability testing using the KT-1000 arthrometer, clinical examination (Lachman and pivot shift tests), functional outcome scores, and radiological evaluation. Magnetic resonance imaging (MRI), including T2 mapping sequences, will be performed at 1 year to evaluate graft maturation, and integration.

02

Conditions studied

  • Anterior Cruciate Ligament (ACL)

Keywords

  • anterior cruciate ligament
  • suture tape augmentation
  • t2 mapping
03

In context

Lead sponsor

Samsun University is the lead sponsor of 81 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 44 years
  • Diagnosis of complete ACL rupture confirmed by clinical examination and imaging
  • Planned primary single-bundle anatomic ACL reconstruction using hamstring autograft
  • Intact contralateral knee
  • Provision of written informed consent

Exclusion criteria

Exclusion Criteria

  • Cartilage lesions grade 2 or higher according to the Outerbridge classification
  • Combined ligament injuries or inflammatory arthritis
  • Tibial slope greater than 12 degrees
  • Advanced knee laxity
  • Revision ACL reconstruction
  • Requirement for additional surgical procedures during the same operation
  • Inability to comply with follow-up protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Standard ACL Reconstruction

    Patients will undergo single-bundle anatomic ACL reconstruction using a quadrupled hamstring (semitendinosus) autograft. Femoral and tibial fixation will be performed using adjustable cortical suspension devices according to standard surgical techniques.

    Procedure: ACL Reconstruction

  • Experimental
    TARS-Augmented ACL Reconstruction

    Patients will undergo the same standard ACL reconstruction procedure with augmentation using the Tape Active Reconstruction System (TARS). Within the TARS technique, high-strength suture tape is applied to provide load sharing and graft protection during the early rehabilitation period.

    Procedure: TARS-Augmented ACL Reconstruction

Interventions

  • ProcedureACL Reconstruction

    ACL reconstruction using semitendinosus tendon autograft

  • ProcedureTARS-Augmented ACL Reconstruction

    Arthroscopic single-bundle ACL reconstruction using a quadrupled semitendinosus tendon autograft was performed with additional Tape Active Reconstruction System (TARS) augmentation. High-strength suture tape was applied to provide load sharing during early rehabilitation. The postoperative rehabilitation protocol was identical to the control group.

06

What researchers measure

Primary outcomes

  1. Side to side difference in anterior tibial translation (mm)

    Anterior tibial translation measured by (Knee laxity Testing device) KT-1000 Arthrometer.

    Time frame: Preoperative and 12 months postoperatively

Secondary outcomes

  1. International Knee Documentation Committee (IKDC) Score

    Patient reported outcome measures of symptoms, sports activity \& knee function. 0-100 points with 0 (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)

    Time frame: 12 months

  2. Marx Activity Rating Scale

    Patient-reported outcome measure of participation in high-demand sports activities, assessing the frequency of running, cutting, decelerating, and pivoting movements. Scores range from 0 to 16, with 0 indicating no participation in these activities and 16 indicating very frequent participation in pivoting and impact activities.

    Time frame: 12 months

  3. Radiological assessment using MRI for graft maturation and integration

    Graft maturation was assessed using MRI with T2 mapping sequences, and T2 values were measured at intra-articular graft regions using standardized regions of interest. Graft integration was assessed according to the Ge et al. grading system (Grade 1-3) based on the quality of graft-bone interface integration

    Time frame: 12 months

07

Study locations

1 site
  • Samsun University
    Samsun, Samsun, Turkey (Türkiye)
08

References and documents

Publications

  • Smith PA, Daniel AV, Stensby JD, Cook CS, Wijdicks CA. Quadriceps Tendon Autograft ACL Reconstruction With Suture Tape Augmentation: Safe Results Based on Minimum 2-Year Follow-up MRI. Orthop J Sports Med. 2024 Apr 11;12(4):23259671241239275. doi: 10.1177/23259671241239275. eCollection 2024 Apr. PubMed 38617885 ↗
  • Kitchen BT, Mitchell BC, Cognetti DJ, Siow MY, Howard R, Carroll AN, Bastrom TP, Edmonds EW. Outcomes After Hamstring ACL Reconstruction With Suture Tape Reinforcement in Adolescent Athletes. Orthop J Sports Med. 2022 Apr 8;10(4):23259671221085577. doi: 10.1177/23259671221085577. eCollection 2022 Apr. PubMed 35425845 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07418476
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Feb 18, 2026
Start date
Feb 28, 2026
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jul 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion